Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Lee's Pharmaceutical Holdings Limited LPCUF

Full chart Compare
Set alert

Price alert · LPCUF

All alert types
0.19 USD 0.00 (+0.00%)

At closeNov 2, 2026, 4:00 PM EST

0.20 Day range 0.20
0.1882 52-week range 0.20
YTD
0.00%
1 year
+1.12%

Financial health

Altman Z-Score

2.55 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

9 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A-4 / 5 overall

  • DCF 1
  • Return on Equity 3
  • Return on Assets 4
  • Debt / Equity 3
  • P/E 4
  • P/B 5

Valuation

P/E 9.3×
FY 2016: 20.7×FY 2017: 23.0×FY 2018: 12.7×FY 2019: 81.4×FY 2020: 68.6×FY 2021: 2.7×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 9.1×FY 2025: 9.3×
FY 2016 5y median 2.7× FY 2025
P/S 0.6×
FY 2016: 5.6×FY 2017: 5.3×FY 2018: 4.7×FY 2019: 4.3×FY 2020: 4.3×FY 2021: 4.2×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.6×FY 2025: 0.6×
FY 2016 5y median 0.6× FY 2025
P/B 0.4×
FY 2016: 3.3×FY 2017: 2.9×FY 2018: 2.4×FY 2019: 2.3×FY 2020: 2.4×FY 2021: 2.1×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.5×FY 2025: 0.4×
FY 2016 5y median 0.4× FY 2025
P/FCF 8.6×
FY 2016: 42.1×FY 2017: 54.0×FY 2018: 346×FY 2019: 135×FY 2020: -37.7×FY 2021: -33.0×FY 2022: 0.0×FY 2023: -0.0×FY 2024: 25.0×FY 2025: 8.6×
FY 2016 5y median 0.0× FY 2025
EV/EBITDA 3.8×
FY 2016: 14.5×FY 2017: 15.3×FY 2018: 9.7×FY 2019: 19.9×FY 2020: 18.7×FY 2021: 2.5×FY 2022: -0.1×FY 2023: 0.2×FY 2024: 3.4×FY 2025: 3.8×
FY 2016 5y median 2.5× FY 2025
EV/Sales 0.6×
FY 2016: 5.2×FY 2017: 4.9×FY 2018: 4.4×FY 2019: 3.8×FY 2020: 4.1×FY 2021: 4.2×FY 2022: -0.0×FY 2023: 0.0×FY 2024: 0.6×FY 2025: 0.6×
FY 2016 5y median 0.6× FY 2025
FCF Yield 11.6%
FY 2016: 2.4%FY 2017: 1.9%FY 2018: 0.3%FY 2019: 0.7%FY 2020: -2.7%FY 2021: -3.0%FY 2022: 15181.7%FY 2023: -9981.2%FY 2024: 4.0%FY 2025: 11.6%
FY 2016 5y median 4.0% FY 2025

Profitability

Gross Margin 50.8%
FY 2016: 71.9%FY 2017: 67.7%FY 2018: 65.6%FY 2019: 65.5%FY 2020: 64.2%FY 2021: 63.7%FY 2022: 62.5%FY 2023: 52.4%FY 2024: 53.8%FY 2025: 50.8%
FY 2016 5y median 53.8% FY 2025
Operating Margin 4.3%
FY 2016: 32.1%FY 2017: 27.4%FY 2018: 41.0%FY 2019: 20.1%FY 2020: 12.5%FY 2021: -0.1%FY 2022: 10.0%FY 2023: 4.1%FY 2024: 8.1%FY 2025: 4.3%
FY 2016 5y median 4.3% FY 2025
Net Margin 6.4%
FY 2016: 27.1%FY 2017: 23.1%FY 2018: 36.8%FY 2019: 5.2%FY 2020: 6.5%FY 2021: 156.9%FY 2022: 4.2%FY 2023: 1.6%FY 2024: 6.7%FY 2025: 6.4%
FY 2016 5y median 6.4% FY 2025
ROE 4.5%
FY 2016: 15.7%FY 2017: 12.9%FY 2018: 18.9%FY 2019: 2.8%FY 2020: 3.7%FY 2021: 80.6%FY 2022: 2.7%FY 2023: 0.8%FY 2024: 5.6%FY 2025: 4.5%
FY 2016 5y median 4.5% FY 2025
ROIC 1.7%
FY 2016: 13.4%FY 2017: 10.9%FY 2018: 16.6%FY 2019: 4.4%FY 2020: 3.6%FY 2021: -0.0%FY 2022: 3.8%FY 2023: 1.2%FY 2024: 3.9%FY 2025: 1.7%
FY 2016 5y median 1.7% FY 2025
ROA 2.7%
FY 2016: 12.2%FY 2017: 10.0%FY 2018: 13.9%FY 2019: 1.7%FY 2020: 2.4%FY 2021: 54.6%FY 2022: 1.8%FY 2023: 0.6%FY 2024: 3.6%FY 2025: 2.7%
FY 2016 5y median 2.7% FY 2025

Growth (YoY)

Revenue 2.5%
FY 2016: 0.8%FY 2017: 8.5%FY 2018: 12.8%FY 2019: 7.1%FY 2020: -0.2%FY 2021: 4.1%FY 2022: -2.6%FY 2023: -14.6%FY 2024: 32.9%FY 2025: 2.5%
FY 2016 FY 2025
Operating Income -45.7%
FY 2016: 4.2%FY 2017: -7.2%FY 2018: 68.7%FY 2019: -47.6%FY 2020: -37.9%FY 2021: -100.5%FY 2022: 17826.1%FY 2023: -64.6%FY 2024: 159.8%FY 2025: -45.7%
FY 2016 FY 2025
EPS (diluted) 0.0%
FY 2016: 10.3%FY 2017: -9.3%FY 2018: 79.5%FY 2019: -84.3%FY 2020: 18.2%FY 2021: 2492.3%FY 2022: -97.4%FY 2023: -67.4%FY 2024: 463.4%FY 2025: 0.0%
FY 2016 FY 2025
Free Cash Flow 194.2%
FY 2016: 268.3%FY 2017: -21.3%FY 2018: -84.3%FY 2019: 155.6%FY 2020: -453.6%FY 2021: -14.9%FY 2022: 143.6%FY 2023: -165.7%FY 2024: 175.1%FY 2025: 194.2%
FY 2016 FY 2025

Financial Health

Current Ratio 1.0×
FY 2016: 2.5×FY 2017: 2.0×FY 2018: 1.5×FY 2019: 1.6×FY 2020: 1.3×FY 2021: 1.0×FY 2022: 1.0×FY 2023: 1.0×FY 2024: 1.0×FY 2025: 1.0×
FY 2016 5y median 1.0× FY 2025
Quick Ratio 0.7×
FY 2016: 2.1×FY 2017: 1.7×FY 2018: 1.2×FY 2019: 1.3×FY 2020: 0.9×FY 2021: 0.7×FY 2022: 0.6×FY 2023: 0.6×FY 2024: 0.6×FY 2025: 0.7×
FY 2016 5y median 0.6× FY 2025
Debt / Equity 0.2×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.2×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -0.2×
FY 2016: -1.1×FY 2017: -1.1×FY 2018: -0.6×FY 2019: -2.6×FY 2020: -1.0×FY 2021: -0.0×FY 2022: -0.1×FY 2023: 0.2×FY 2024: 0.0×FY 2025: -0.2×
FY 2016 5y median -0.0× FY 2025
Interest Coverage 5.5×
FY 2016: 87.9×FY 2017: 71.8×FY 2018: 112×FY 2019: 42.5×FY 2020: 28.2×FY 2021: -0.2×FY 2022: 18.6×FY 2023: 3.7×FY 2024: 8.2×FY 2025: 5.5×
FY 2016 5y median 5.5× FY 2025

Dividends

Dividend Yield 3.2%
FY 2016: 1.2%FY 2017: 1.3%FY 2018: 1.2%FY 2019: 1.1%FY 2020: 0.7%FY 2021: 0.7%FY 2022: 5250.3%FY 2023: 2305.3%FY 2024: 2.1%FY 2025: 3.2%
FY 2016 5y median 3.2% FY 2025
Payout Ratio 30.1%
FY 2016: 25.0%FY 2017: 28.7%FY 2018: 14.7%FY 2019: 95.4%FY 2020: 48.7%FY 2021: 1.8%FY 2022: 47.1%FY 2023: 63.5%FY 2024: 19.0%FY 2025: 30.1%
FY 2016 5y median 30.1% FY 2025

Annual · latest fiscal year ends 2025-12-31